Clinical Trial Update: TNF-blocking Therapy in Combination With Disease-modifying Antirheumatic Drugs in Early Rheumatoid Arthritis [Phase 4]

View source ↗

Summary

This update covers a Phase 4 clinical trial evaluating TNF-blocking therapy in combination with disease-modifying antirheumatic drugs for early rheumatoid arthr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• TNF-blocking therapy

Snippet

Sponsor: University of Helsinki | Conditions: Rheumatoid Arthritis | Phase 4 | Status: UNKNOWN